Healthtech Startups

My NextDerma is a telemedicine platform that connects patients with dermatologists for virtual consultations, diagnoses, and prescription fulfillment in Mexico. The service integrates a pharmacy offering dermatological products and treatments, delivered directly to customers' homes.

2 investors

My Clinic is a private family medical clinic in Prague offering comprehensive healthcare services across 85 specialists in 30 medical specialties. The clinic focuses on disease prevention, diagnosis, and targeted treatment with personalized care and extended consultation times.

2 investors

MyEyeDr. is an optometry practice network providing vision care services across the United States. The company prioritizes community engagement through volunteer eye care services, medical missions, and partnerships with local organizations.

2 investors

2 investors

Arbiter is an agentic care orchestration platform that identifies the next best action for a patient, sends personalized multi-channel outreach, and drives appointment scheduling and completion of care such as screenings and open HEDIS measures. It serves healthcare organizations and health plans, combining AI-driven automation with in-house nurses for escalations.

2 investors

myo is a communication app for elderly care facilities that connects nursing homes with residents' families and service providers such as laundries, pharmacies, and podiatrists, supporting photo/video sharing, video calls, and kitchen/meal management. It targets German elderly care institutions to improve workflows and transparency with families.

2 investors

myTomorrows operates an online platform and patient navigation service that helps patients and their physicians discover and access clinical trials, expanded access programs, and treatments in development. It connects patients, treating physicians, and BioPharma research teams, supporting patient recruitment, expanded access management, and real-world data collection.

2 investors

Mytonomy provides a cloud-based platform that delivers video and multimedia content to enable patient education and engagement with healthcare providers. The platform serves health systems, health plans, and healthcare organizations to improve patient outcomes and reduce care costs through digital patient engagement.

2 investors

Weimai is a digital health platform providing comprehensive, full-cycle healthcare services to populations across China through AI-powered disease management technology. The company operates China's largest full-condition management service platform, partnering with hospitals and healthcare providers to deliver personalized medical and wellness services.

2 investors

N1 Health offers a cloud-based AI platform that predicts which individuals to engage with specific health interventions to improve health outcomes, supported by its data science and customer experience teams. It serves health plans and healthcare payers seeking better member segmentation and engagement.

2 investors

NAAMA Studios provides laser tattoo removal and permanent makeup removal services using proprietary LightSense® technology, an FDA-cleared and clinically-backed system designed for safety and efficacy across all skin types.

2 investors

Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains. The company is based in Glasgow, United Kingdom.

2 investors

NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.

2 investors

Nanos Medical is a Chinese medical device company specializing in otorhinolaryngology and minimally invasive surgery equipment, offering diagnostic and surgical solutions for ENT and head-neck procedures. The company manufactures and distributes medical consumables, plasma surgery systems, endoscopic cameras, and related surgical instruments.

2 investors

Nanostics is a precision health company developing non-invasive diagnostic tests and medical devices that use machine learning to detect and assess aggressive cancers such as prostate cancer, aiming to improve diagnosis and healthcare decisions. It serves clinicians and patients in the cancer diagnostics field.

2 investors

NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.

2 investors

Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader. The platform serves biotechnology research and therapeutic analysis workflows.

2 investors

Narrable Health provides an AI platform for home health agencies that automates administrative and clinical documentation work, including AI-generated OASIS notes, compliance QA, billing, and referral growth. It serves home health organizations across roles such as executives, directors of nursing, operations, and finance.

2 investors

Everlywell offers at-home and in-person laboratory tests for various health conditions including blood biomarkers, food sensitivity, STI screening, and hormone levels, served directly to consumers through digital and virtual care services.

2 investors

CMR Naviscan develops a breast imaging technology aimed at improving invasive cancer detection rates and reducing unnecessary biopsies, particularly in women with dense breast tissue. It positions its modality as a lower-cost alternative that addresses limitations of existing breast cancer screening methods.

2 investors

Navitas Life Sciences is a global clinical research partner providing clinical, regulatory, safety, and data management solutions to pharmaceutical, biotech, and federal agencies for drug development and patient safety. The company combines industry expertise with proprietary technology platforms to accelerate clinical trials and regulatory processes.

2 investors

Navi develops a medical device — an ECG-based catheter tip location system for newborn and pediatric patients — to help doctors and nurses in neonatal and pediatric intensive care units deliver better vascular access care. The company works with clinicians internationally to improve pediatric patient outcomes.

2 investors

Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications. The company serves pharmaceutical and biotech organizations seeking advanced cellular models to accelerate therapeutic development and validate drug candidates.

2 investors

Ncerebro (주식회사 엔서) develops medical and wellness devices, including near-infrared spectroscopy-based instruments for measuring blood oxygen saturation, olfactory-based screening for cognitive impairment, and brain wellness devices for sleep and stress. The company serves surgical and neurological healthcare use cases.

2 investors